 The U.S. will pay vaccine maker Moderna $176 million to develop an mRNA pandemic flu vaccine. It could be used to treat bird flu in people, as cases in dairy cattle increase across the country. The Department of Health and Human Services says it's funding the development of a vaccine based on the same technology that will allow the rapid development of the COVID vaccine.